E
Mydecine Innovations Group Inc.
MYCOF
$0.0045
-$0.0006-11.77%
E
Sell
3/14/2023Downgrade
Mydecine Innovations Group Inc. (MYCOF) was downgraded to E+ from D- on 03/14/2023.
Mydecine Innovations Group Inc. (MYCOF) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D- from E+ on 02/23/2023.
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
Mydecine Innovations Group Inc. (MYCOF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the solvency index, growth index and volatility index. Debt to equity increased from -2.43 to -1.32, and the quick ratio declined from 0.17 to 0.13.
Mydecine Innovations Group Inc. (MYCOF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the solvency index, growth index and volatility index. Debt to equity increased from -2.43 to -1.32, and the quick ratio declined from 0.17 to 0.13.
D
Sell
11/2/2022Downgrade
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from D on 11/2/2022 due to a decline in the total return index and volatility index.
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from D on 11/2/2022 due to a decline in the total return index and volatility index.
D
Sell
10/18/2022Upgraded
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D from D- on 10/18/2022 due to an increase in the volatility index.
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D from D- on 10/18/2022 due to an increase in the volatility index.
D
Sell
10/3/2022Downgrade
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from D on 10/3/2022 due to a noticeable decline in the solvency index and volatility index.
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from D on 10/3/2022 due to a noticeable decline in the solvency index and volatility index.
D
Sell
5/23/2022Upgraded
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D from E+ on 5/23/2022 due to a substantial increase in the growth index, valuation index and volatility index. Operating cash flow increased 66.07% from -$3.77M to -$1.28M, EBIT increased 49.97% from -$6.94M to -$3.47M, and earnings per share increased from -$1.7623 to -$0.9453.
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D from E+ on 5/23/2022 due to a substantial increase in the growth index, valuation index and volatility index. Operating cash flow increased 66.07% from -$3.77M to -$1.28M, EBIT increased 49.97% from -$6.94M to -$3.47M, and earnings per share increased from -$1.7623 to -$0.9453.
E
Sell
4/20/2022Downgrade
Mydecine Innovations Group Inc. (MYCOF) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index.
Mydecine Innovations Group Inc. (MYCOF) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index.
D
Sell
4/18/2022Downgrade
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from D on 4/18/2022 due to a large decline in the solvency index, growth index and total return index. Debt to equity increased from 0.05 to 21.07, total revenue declined 11,100% from $100 to -$11, and earnings per share declined from -$0.015 to -$0.0355.
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from D on 4/18/2022 due to a large decline in the solvency index, growth index and total return index. Debt to equity increased from 0.05 to 21.07, total revenue declined 11,100% from $100 to -$11, and earnings per share declined from -$0.015 to -$0.0355.
D
Sell
11/9/2021Upgraded
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D from E+ on 11/09/2021.
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Mydecine Innovations Group Inc. (MYCOF) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the solvency index, volatility index and growth index. Debt to equity increased from 0.03 to 0.05, total revenue declined 66.67% from $12.6 to $4.2, and earnings per share declined from -$0.0197 to -$0.0286.
Mydecine Innovations Group Inc. (MYCOF) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the solvency index, volatility index and growth index. Debt to equity increased from 0.03 to 0.05, total revenue declined 66.67% from $12.6 to $4.2, and earnings per share declined from -$0.0197 to -$0.0286.
D
Sell
1/14/2021Upgraded
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D from D- on 1/14/2021 due to a noticeable increase in the total return index and volatility index.
Mydecine Innovations Group Inc. (MYCOF) was upgraded to D from D- on 1/14/2021 due to a noticeable increase in the total return index and volatility index.
D
Sell
12/2/2020Downgrade
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from D on 12/2/2020 due to a decline in the growth index, valuation index and volatility index. Earnings per share declined from -$0.0256 to -$0.0562, EBIT declined 93.95% from -$2.19M to -$4.25M, and total revenue declined 7.5% from $50.7 to $46.9.
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from D on 12/2/2020 due to a decline in the growth index, valuation index and volatility index. Earnings per share declined from -$0.0256 to -$0.0562, EBIT declined 93.95% from -$2.19M to -$4.25M, and total revenue declined 7.5% from $50.7 to $46.9.
D
Sell
5/18/2020Upgraded
NewLeaf Brands Inc. (NLBIF) was upgraded to D from D- on 5/18/2020 due to an increase in the volatility index and total return index.
NewLeaf Brands Inc. (NLBIF) was upgraded to D from D- on 5/18/2020 due to an increase in the volatility index and total return index.
D
Sell
5/1/2020Downgrade
NewLeaf Brands Inc. (NLBIF) was downgraded to D- from D on 5/1/2020 due to a large decline in the total return index and volatility index.
NewLeaf Brands Inc. (NLBIF) was downgraded to D- from D on 5/1/2020 due to a large decline in the total return index and volatility index.
D
Sell
5/15/2019Upgraded
NewLeaf Brands Inc. (NWGFF) was upgraded to D from D- on 5/15/2019 due to an increase in the valuation index and growth index. Operating cash flow increased 107.05% from -$546.2 to $38.5.
NewLeaf Brands Inc. (NWGFF) was upgraded to D from D- on 5/15/2019 due to an increase in the valuation index and growth index. Operating cash flow increased 107.05% from -$546.2 to $38.5.
D
Sell
11/30/2018Downgrade
New Age Brands Inc. (NWGFF) was downgraded to D- from D+ on 11/30/2018 due to a decline in the efficiency index, valuation index and growth index. Total revenue declined 25.66% from $68.6 to $51.
New Age Brands Inc. (NWGFF) was downgraded to D- from D+ on 11/30/2018 due to a decline in the efficiency index, valuation index and growth index. Total revenue declined 25.66% from $68.6 to $51.
D
Sell
11/27/2018Upgraded
New Age Brands Inc. (NWGFF) was upgraded to D+ from D on 11/27/2018 due to a substantial increase in the total return index, efficiency index and growth index. Total revenue increased 988.89% from $6.3 to $68.6.
New Age Brands Inc. (NWGFF) was upgraded to D+ from D on 11/27/2018 due to a substantial increase in the total return index, efficiency index and growth index. Total revenue increased 988.89% from $6.3 to $68.6.
D
Sell
5/7/2018Upgraded
New Age Farm Inc. (NWGFF) was upgraded to D from D- on 5/7/2018 due to an increase in the solvency index, volatility index and total return index. The quick ratio increased from 0.01 to 1.62, and debt to equity declined from 0.83 to 0.06.
New Age Farm Inc. (NWGFF) was upgraded to D from D- on 5/7/2018 due to an increase in the solvency index, volatility index and total return index. The quick ratio increased from 0.01 to 1.62, and debt to equity declined from 0.83 to 0.06.
D
Sell
10/17/2017None
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from U on 10/17/2017.
Mydecine Innovations Group Inc. (MYCOF) was downgraded to D- from U on 10/17/2017.
OTC PK
03/07/2025 2:07PM Eastern
Quotes delayed
